How Often Should We Test for Hepatitis C in People Who Inject Drugs?
A major challenge associated with hepatitis screening is the loss to follow-up that occurs in people who inject drugs.
A major challenge associated with hepatitis screening is the loss to follow-up that occurs in people who inject drugs.
Unrestricted use of DAAs may be an invaluable component of preventing HCV transmission by reducing the infectious pool of individuals.